Representative Marjorie Taylor Greene (R-Georgia) recently bought shares of ASML Holding (NASDAQ:ASML). In a filing disclosed on November 27th, the Representative disclosed that they had bought ...

Elevai Labs Inc. has taken a significant step to ensure compliance with Nasdaq’s minimum bid price requirement by implementing a 1-for-200 reverse stock split. The decision, outlined in a recent ...

Surge Components, Inc. (OTCMKTS:SPRS) recently convened its 2024 Annual Meeting of Stockholders on November 26, 2024. The company shared the voting outcomes from the meeting on various proposals. The ...

Shares of AST SpaceMobile, Inc. (NASDAQ:ASTS – Get Free Report) were down 0.4% on Thursday . The company traded as low as $23.06 and last traded at $23.29. Approximately 6,944,095 shares traded hands ...

EQT Corporation, a Pennsylvania-based energy company, announced on November 22, 2024, that it has entered into a significant transaction through its subsidiaries, including EQM Midstream Partners, LP.

10 Stocks to Sell NOW! 3 Stocks to DOUBLE This Year The 10 Best Stocks to Own in 2023 7 Stocks to Buy and Hold Forever Akanda Corp., through its subsidiaries, engages in the cultivation ...

Fidelity MSCI Information Technology Index ETF Stock Down 0.4 % Shares of FTEC opened at $184.47 on Thursday. Fidelity MSCI Information Technology Index ETF has a twelve month low of $133.79 and a ...

Shares of Cipher Mining Inc. (NASDAQ:CIFR – Get Free Report) gapped down prior to trading on Tuesday after an insider sold shares in the company.The stock had previously closed at $7.43, but ...

10 Stocks to Sell NOW! 3 Stocks to DOUBLE This Year The 10 Best Stocks to Own in 2023 7 Stocks to Buy and Hold Forever B.P. Marsh & Partners PLC invests in early-stage financial services ...

Shares of NASDAQ PCH opened at $41.50 on Tuesday. The stock has a market cap of $3.27 billion, a price-to-earnings ratio of 197.62 and a beta of 1.14. PotlatchDeltic has a 52 week low of $37.06 ...

Insider Activity In other news, VP Ashraf K. Malik sold 7,201 shares of the stock in a transaction dated Friday, October 4th. The shares were sold at an average price of $90.02, for a total ...

Oruka Therapeutics’ rivals have higher revenue and earnings than Oruka Therapeutics. Oruka Therapeutics is trading at a higher price-to-earnings ratio than its rivals, indicating that it is ...